HIPRAGUMBORO-CH/80

Indications

• Bursitis
• Tendinitis
• Osteoarthritis
• Rheumatoid arthritis
• Post-operative inflammation
• Other inflammatory joint conditions

Dosage

Children: Refer to the BNF for Children for appropriate dosing information based on age and condition.

Adults: Refer to specific BNF guidelines for dosing as it varies by the condition and the specific agent used.

Mechanism of action

The mechanism of action for agents indicated for bursal inflammation typically involves the modulation of immune response and reduction of inflammatory processes. This can include inhibition of pro-inflammatory cytokines, suppression of immune cell activation, or enhancement of anti-inflammatory mediators. Specific pathways may involve the NF-kB signaling pathway, phospholipase A2 inhibition, and modulation of arachidonic acid metabolism.

Pharmacodynamics

Pharmacodynamics for drugs affecting bursal conditions often includes the reduction of pain and swelling, improved mobility, and overall enhancement of joint function. The efficacy of these agents can be measured through clinical outcomes such as pain scales, range of motion assessments, and patient-reported symptom relief.

Pharmacokinetics

Pharmacokinetics of bursal-related therapies may vary widely depending on the specific drug class being considered. Generally, these agents may be administered orally or parenterally, with absorption rates and bioavailability influenced by formulation and route of administration. Metabolism typically occurs in the liver, and elimination can occur via renal pathways or through fecal excretion, depending on the molecular structure of the drug.

Pregnancy

There is limited information regarding the safety of bursal in pregnancy. It is advisable to avoid use unless the benefits outweigh the risks.

Breast-feeding

The excretion of bursal in human milk is unknown. Caution is recommended when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Indications

• Cancer (e.g., leukemia, lymphoma)
• Autoimmune diseases (e.g., lupus, rheumatoid arthritis)
• Cardiovascular diseases (e.g., myocardial infarction)
• Neurological disorders (e.g., Parkinson's disease, multiple sclerosis)
• Orthopedic conditions (e.g., osteoarthritis)
• Genetic disorders (e.g., cystic fibrosis)

Dosage

Children: Dosage varies widely based on the cell type and condition being treated. Refer to specific treatment protocols and guidelines.

Adults: Dosage varies widely based on the cell type and condition being treated. Refer to specific treatment protocols and guidelines.

Mechanism of action

Cell therapies can function through several mechanisms, including differentiation into specific cell types, secretion of bioactive factors that promote tissue repair, and modulation of the immune response. For example, in the case of stem cells, they can migrate to sites of injury and contribute to tissue regeneration and repair.

Pharmacodynamics

The pharmacodynamics of cell therapy depend on the type of cells used and their intended purpose. For immune cell therapies, such as CAR T-cell therapy, the activated T-cells seek out and destroy cancer cells. In regenerative medicine, stem cells can differentiate into various cell types, potentially restoring normal function in damaged tissues. The therapeutic effects may also be mediated through paracrine signaling, where the cells release signaling molecules that enhance healing processes.

Pharmacokinetics

The pharmacokinetics of cell therapies include factors such as cell migration, engraftment, and survival within the host. After administration, cells may migrate to the target tissue, where they ideally engraft and proliferate. The lifespan of administered cells can vary significantly depending on the cell type and the patient's immune response. For example, some immune cells may have a short half-life, while stem cells may persist longer and contribute to ongoing tissue repair.

Pregnancy

There is limited data on the safety of this drug during pregnancy. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised when administering this drug to breastfeeding mothers, as it may pass into breast milk and affect the nursing infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Hypertension
• Attention-deficit hyperactivity disorder (ADHD)
• Opioid withdrawal
• Pain management in certain chronic pain conditions

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines based on clinical condition.

Adults: Refer to the BNF for specific dosing guidelines based on clinical condition.

Mechanism of action

Clonidine exerts its effects primarily through the stimulation of alpha-2 adrenergic receptors in the brain, particularly in the locus coeruleus. This stimulation results in decreased release of norepinephrine, thereby reducing sympathetic outflow from the central nervous system. The reduction in norepinephrine leads to vasodilation and a decrease in heart rate, effectively lowering blood pressure.

Pharmacodynamics

Clonidine's pharmacodynamic profile is characterized by its ability to decrease heart rate and lower blood pressure through central nervous system-mediated actions. It is also noted for its efficacy in reducing withdrawal symptoms from opioids and its potential role in managing anxiety and hyperactivity in children. The onset of action for oral clonidine is typically within 30 to 60 minutes, with peak effects occurring in 2 to 4 hours.

Pharmacokinetics

Clonidine is well-absorbed after oral administration, with a bioavailability of approximately 75%. It undergoes extensive first-pass metabolism in the liver, which can affect its overall effectiveness. The drug has a volume of distribution of 2-4 L/kg and is approximately 20% bound to plasma proteins. Clonidine is primarily excreted in the urine as unchanged drug and metabolites. Its half-life is approximately 12 to 16 hours, allowing for once or twice daily dosing in most cases.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Headache
• Fatigue
• Dizziness
• Neutropenia
• Thrombocytopenia
• Anemia
• Increased risk of infections

Interactions

• May interact with other medications that affect bone marrow function
• Caution with drugs that can cause hepatotoxicity
• May enhance the effects of anticoagulants

Precautions

• Monitor complete blood count regularly
• Assess liver function prior to initiation and during therapy
• Use caution in patients with a history of liver disease
• Consider risk of infection due to immunosuppressive effects

Pregnancy

Use only if the potential benefit justifies the potential risk to the fetus. Limited data available on use in pregnancy.

Breast-feeding

Caution is advised as it is not known if this drug is excreted in human milk. Weigh the risk of potential adverse effects in the infant against the benefits of therapy.

Storage

Store at controlled room temperature, away from light and moisture. Keep out of reach of children.

Formulations

• Oral tablets
• Injectable form

Indications

• Bacterial infections
• Fungal infections
• Tuberculosis
• Sepsis
• Pneumonia
• Urinary tract infections
• Skin infections
• Gastrointestinal infections

Dosage

Children: Refer to specific antimicrobial agents prescribed based on culture results, as culture itself does not have a dosage.

Adults: Refer to specific antimicrobial agents prescribed based on culture results, as culture itself does not have a dosage.

Mechanism of action

The mechanism of action for culture involves the growth of microorganisms in a nutrient-rich environment, where various media support the proliferation of specific types of bacteria or fungi. This allows for the identification of pathogens based on their growth patterns, colony morphology, and biochemical reactions.

Pharmacodynamics

Culture does not have pharmacodynamics as it is not a drug but a diagnostic technique. However, understanding the growth requirements of different microorganisms can inform the selection of appropriate media and conditions for optimal growth. This knowledge is critical for the accurate identification of pathogens and the determination of their susceptibility to antimicrobial agents.

Pharmacokinetics

As a laboratory technique, culture does not have pharmacokinetics. The focus is on the growth and identification of microorganisms rather than the absorption, distribution, metabolism, and excretion of a drug.

Pregnancy

Use should be avoided unless deemed essential by a healthcare professional.

Breast-feeding

Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Dosage

Children: Refer to specific medications used to treat the particular disease for dosing information.

Adults: Refer to specific medications used to treat the particular disease for dosing information.

Mechanism of action

The mechanism of action varies significantly depending on the specific disease in question. For infectious diseases, pathogens may interact with host cells, leading to inflammation, immune response activation, or tissue damage. Chronic diseases often involve complex interactions between genetic factors, lifestyle choices, and environmental influences. For example, in autoimmune diseases, the immune system mistakenly targets healthy cells, leading to inflammation and tissue destruction.

Pharmacodynamics

Pharmacodynamics of disease involves understanding how the disease state affects physiological functions and the body's response to treatment. In infectious diseases, the presence of pathogens can lead to altered immune responses, while chronic diseases may involve changes in metabolic pathways, hormonal balances, or cellular functions. Medications targeting disease processes aim to restore normal function, alleviate symptoms, or eradicate pathogens.

Pharmacokinetics

Pharmacokinetics is not applicable to the term 'disease' as it refers to the movement of drugs within the body, including absorption, distribution, metabolism, and excretion of specific medications used to treat diseases. Each medication will have its own pharmacokinetic profile depending on its chemical properties and the disease being treated.

Indications

• Clinical term 1
• Common term 1
• Clinical term 2
• Common term 2

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Dose acts by modulating the activity of specific neurotransmitter receptors and ion channels, influencing various physiological pathways. Its precise mechanism may involve interactions with G-protein coupled receptors, leading to downstream signaling effects that impact cellular responses.

Pharmacodynamics

Dose exhibits a range of effects depending on the dosage and target tissues. It is known to alter neurotransmitter release, affect ion conductance, and influence metabolic pathways, thereby contributing to its therapeutic efficacy and potential side effects.

Pharmacokinetics

Dose is generally absorbed following administration, with peak plasma concentrations occurring within a specified timeframe. Its distribution is influenced by tissue binding and permeability across cell membranes. The drug is metabolized primarily in the liver, with metabolites being excreted via renal and biliary routes. The half-life can vary based on individual patient factors, including age, liver function, and other concurrent medications.

Indications

• Bacterial infections
• Viral infections
• Fungal infections
• Parasitic infections
• Sepsis
• Pneumonia
• Urinary tract infections
• Skin and soft tissue infections

Dosage

Children: Refer to specific drug monographs for dosing information based on the type of infection and child's age and weight.

Adults: Refer to specific drug monographs for dosing information based on the type of infection and pathogen involved.

Mechanism of action

The mechanism of action of antimicrobial agents varies widely depending on the class of drug. For example, antibiotics may inhibit cell wall synthesis, protein synthesis, or nucleic acid synthesis in bacteria. Antivirals often target viral replication processes, while antifungal agents disrupt cell membrane integrity or inhibit essential metabolic pathways in fungi.

Pharmacodynamics

Pharmacodynamics of infectious disease treatments involves understanding the drug's effects on the pathogen, including the minimum inhibitory concentration (MIC) that inhibits bacterial growth, or the time and concentration needed to effectively reduce viral load. The efficacy of the antimicrobial therapy is influenced by factors such as the site of infection, the immune response of the host, and the susceptibility profile of the pathogen.

Pharmacokinetics

Pharmacokinetics of antimicrobial agents encompasses absorption, distribution, metabolism, and excretion. For instance, antibiotics may be well absorbed orally but have variable bioavailability. Distribution can be affected by tissue permeability and protein binding. Metabolism may occur in the liver, and excretion is primarily renal, influencing dosing in patients with renal impairment.

Pregnancy

Consult healthcare professional; safety varies by specific infectious agent and treatment.

Breast-feeding

Consult healthcare professional; safety varies by specific infectious agent and treatment.

Storage

Store in a cool, dry place, away from direct sunlight; specific storage may vary by formulation.

Indications

• Bacterial infections
• Viral infections
• Fungal infections
• Parasitic infections
• Sepsis
• Pneumonia
• Urinary tract infections
• Skin infections

Dosage

Adults: Dosage varies widely based on the specific antimicrobial agent used, the type of infection, and patient factors. Refer to specific guidelines or the BNF for detailed dosing information.

Mechanism of action

Antimicrobial agents target specific pathways or structures within the infective organism to inhibit its growth or kill it. For example, antibiotics may inhibit cell wall synthesis, protein synthesis, or nucleic acid synthesis in bacteria. Antivirals may interfere with viral replication, while antifungals can disrupt fungal cell membranes or inhibit fungal cell wall synthesis. The specific mechanism depends on the class of the antimicrobial agent used.

Pharmacodynamics

The pharmacodynamic properties of antimicrobial agents include their spectrum of activity, potency, and the relationship between drug concentration and effect. The effectiveness of these agents is often measured in terms of minimum inhibitory concentration (MIC), which indicates the lowest concentration of the drug needed to inhibit the growth of a microorganism. Factors such as time-dependence or concentration-dependence of the drug’s action are also key considerations in their pharmacodynamics.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of antimicrobial agents. The bioavailability of these drugs can vary significantly, influencing their effectiveness in treating infections. For instance, some antibiotics are better absorbed orally, while others require intravenous administration. Distribution patterns can also be influenced by factors such as tissue penetration, and some medications may undergo significant hepatic metabolism before excretion, typically via the kidneys. The half-life of the drug informs dosing frequency and regimen.

Contra-indications

• Hypersensitivity to the active substance or any of the excipients
• Severe renal impairment
• Active gastrointestinal bleeding

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Rash
• Allergic reactions
• Dizziness
• Headache

Interactions

• Antacids may reduce the absorption
• Probenecid may increase plasma concentrations
• Certain antibiotics may have additive toxic effects

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of superinfection
• Evaluate liver function periodically
• Consider risk of Clostridium difficile-associated diarrhea

Pregnancy

Use only if clearly needed, as safety in pregnancy has not been established.

Breast-feeding

Use with caution, as it may be excreted in breast milk and could affect the infant.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Formulations

• Tablets
• Oral suspension
• Injectable solution

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Infectious diseases caused by bacteria
• Viral infections
• Fungal infections
• Parasitic infections

Dosage

Children: Refer to the BNF for Children for specific dosing information based on the organism type and age.

Adults: Refer to specific guidelines for antimicrobial therapy based on the organism type and infection site.

Mechanism of action

The mechanism of action of organisms varies widely depending on the type. For example, bacteria can reproduce rapidly and may produce toxins that interfere with host cellular functions. Viruses invade host cells and hijack cellular machinery to replicate. Fungi can disrupt cell membranes and evade the immune response. Each organism has unique pathways for infection, propagation, and interaction with host defenses.

Pharmacodynamics

Pharmacodynamics of organisms relates to their growth, replication, and the effects they have on the host. Pathogenic bacteria can elicit immune responses leading to inflammation. Viruses often induce cellular apoptosis or necrosis, while fungi can cause damage through their metabolic byproducts. The interaction between the organism and the host's immune system is crucial in determining the severity of the disease.

Pharmacokinetics

Pharmacokinetics of organisms is not applicable as they do not have a pharmacokinetic profile like drugs. Instead, their behavior in the host can be characterized by their replication rate, survival in various environments, and the ability to develop resistance to antimicrobial agents. The distribution of organisms in the body, their elimination through immune responses, and their potential to establish reservoirs or persistence in host tissues are critical.

Indications

• Influenza
• HIV/AIDS
• Hepatitis B and C
• Herpes simplex virus infections
• Cytomegalovirus infections
• COVID-19
• Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.